- Home
- CXDO vs OBIO Comparison
CXDO vs OBIO Comparison
Compare CXDO & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXDO
- OBIO
- Stock Information
- Founded
- CXDO 1995
- OBIO 2017
- Country
- CXDO United States
- OBIO United States
- Employees
- CXDO 185
- OBIO N/A
- Industry
- CXDO Telecommunications Equipment
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- CXDO Telecommunications
- OBIO Health Care
- Exchange
- CXDO Nasdaq
- OBIO Nasdaq
- Market Cap
- CXDO 196.8M
- OBIO 172.1M
- IPO Year
- CXDO 1998
- OBIO N/A
- Fundamental
- Price
- CXDO $6.25
- OBIO $3.61
- Analyst Decision
- CXDO Strong Buy
- OBIO Strong Buy
- Analyst Count
- CXDO 4
- OBIO 4
- Target Price
- CXDO $8.75
- OBIO $14.00
- AVG Volume (30 Days)
- CXDO 81.8K
- OBIO 368.8K
- Earning Date
- CXDO 11-04-2025
- OBIO 11-12-2025
- Dividend Yield
- CXDO N/A
- OBIO N/A
- EPS Growth
- CXDO 13.31
- OBIO N/A
- EPS
- CXDO 0.11
- OBIO N/A
- Revenue
- CXDO $64,476,000.00
- OBIO $2,944,000.00
- Revenue This Year
- CXDO $13.46
- OBIO $29.26
- Revenue Next Year
- CXDO $11.27
- OBIO $10.65
- P/E Ratio
- CXDO $56.98
- OBIO N/A
- Revenue Growth
- CXDO 13.10
- OBIO 41.61
- 52 Week Low
- CXDO $3.75
- OBIO $2.20
- 52 Week High
- CXDO $7.34
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- CXDO 48.35
- OBIO 57.31
- Support Level
- CXDO $6.00
- OBIO $3.53
- Resistance Level
- CXDO $6.29
- OBIO $4.10
- Average True Range (ATR)
- CXDO 0.23
- OBIO 0.36
- MACD
- CXDO 0.02
- OBIO 0.02
- Stochastic Oscillator
- CXDO 59.09
- OBIO 60.59
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.